GlassScriptPhysician profile
Austin Trent
NPI 1912581893
$1,294.28
in general payments reported to CMS, 2019-2025
16 companies · $1,091 in 2025
The $1,091 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $89.18 · 2024: $114 · 2025: $1,091.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,205.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $335.94 | 2025 | Cardiomems, Coroflow, Xience Skypoint |
| Astrazeneca Pharmaceuticals LP | $190.21 | 2024-2025 | Wainua, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.61 | 2024-2025 | Jardiance |
| Edwards Lifesciences Corporation | $109.52 | 2025 | |
| Novartis Pharmaceuticals Corporation | $94.21 | 2024-2025 | |
| Horizon Therapeutics Plc | $89.18 | 2022 | |
| Merck Sharp & Dohme LLC | $75.43 | 2025 | Verquvo |
| Boston Scientific Corporation | $58.44 | 2025 | Farapulse |
| Alnylam Pharmaceuticals INC. | $47.14 | 2025 | Onpattro |
| Abiomed | $41.25 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.55 | 2025 | |
| Getinge USA Sales, LLC | $24.38 | 2025 | Cardiosave Rescue |
| Pfizer INC. | $19.75 | 2025 | |
| Almatica Pharma LLC | $18.70 | 2024 | Teriparatide |
| Bridgebio Pharma, INC. | $16.31 | 2025 | Attruby |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $13.66 | 2025 | Guideliner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Trent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.